Differences in the characteristics of clinical trial subjects and external controls complicate interpretation of eli-cel's efficacy, the FDA said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
